Types of hormonal therapy

page_title_detailed

About Breast Cancer>Treatments>Hormonal therapy>Types of hormonal therapy > Toremifene citrate

Toremifene citrate

general_content

Toremifene citrate is a hormonal therapy that is FDA approved to treat hormone receptor-positive metastatic breast cancer. It is a SERM, or selective estrogen receptor modulator, a medicine that prevents estrogen signals from getting to breast cancer cells. They are given as daily pills.

on_this_page

On this page

general_content

How toremifene citrate works

Toremifene citrate is closely related to tamoxifen. Like tamoxifen, it works by blocking estrogen from reaching estrogen receptors on breast cancer cells. Without the estrogen, the cancer cells can’t grow as well as they can with it.

Back to top
general_content

Who gets toremifene citrate

Toremifene citrate may be given if you have hormone receptor-positive metastatic breast cancer.

It is not used often in the United States, but toremifene citrate is an FDA approved treatment for metastatic breast cancer. Outside the U.S., this medicine is used for both early-stage and metastatic disease.

Back to top
general_content

How toremifene citrate is given

Toremifene citrate is given as a daily pill. Because your body makes estrogen every day, it’s important to take toremifene citrate every day.

Back to top
general_content

Side effects and things to remember

Common side effects of toremifene citrate are:

Less common side effects of toremifene citrate are:

Toremifene citrate can cause changes in your heart rhythm, so let your doctors know if you have a history of irregular heartbeat.

Your doctor, pharmacist or nurse can help you manage your side effects. You can also go to our section on Side Effects for more information.

Back to top
related_resources_article_carousel

Related resources

Hormone receptor-positive MBC

04/02/25 | BY: Pallav K. Mehta

Learn more about hormone receptor-positive metastatic breast cancer, which means the stage IV breast cancer is hormone-sensitive.

Read More
 | 6 Min. Read |

Living with Metastatic Breast Cancer

04/02/25 | BY: LBBC Staff

Living with a metastatic breast cancer diagnosis can be overwhelming, but there are many ways to adapt to your situation and find the support you need.

Read More
 | 11 Min. Read |

Datopotamab deruxtecan

04/02/25 | BY: Sara Hurvitz

Datopotamab deruxtecan (Datroway) is approved to treat hormone receptor-positive, HER2-negative metastatic breast cancer. It is an antibody-drug conjugate, a treatment that delivers chemotherapy directly to cancer cells.

Read More
 | 6 Min. Read

Metastatic

02/28/25 | BY: LBBC Staff

Metastatic breast cancer describes a type of breast cancer in which the cells have broken away from their original location to form a new tumor in different tissue or a different organ.

Read More
 | 11 Min. Read |

Tamoxifen

02/23/25 | BY: Reshma L. Mahtani, Brooke Worster

Tamoxifen is a type of hormonal therapy called a SERM, or selective estrogen receptor modulator, a medicine that prevents estrogen signals from getting to breast cancer cells.

Read More
 | 11 Min. Read |

Targeted therapy for hormone receptor-positive breast cancer

02/21/25 | BY: Sameer Gupta, Pallav K. Mehta

Targeted therapies are treatments that target specific proteins or markers on or within cancer cells that help cancer cells grow. There are many different kinds of targeted therapy, including CDK 4/6 inhibitors.

Read More
 | 12 Min. Read |

Tests for metastatic breast cancer

01/21/25 | BY: Debu Tripathy

Many different tests can be involved in a metastatic breast cancer diagnosis. These tests can confirm the extent of the cancer and determine the most effective treatments.

Read More
 | 11 Min. Read |

Inavolisib

12/11/24 | BY: Rita Nanda

Inavolisib (Itovebi) is a new targeted therapy shown to reduce progression of certain hormone receptor-positive, HER2-negative, PIK3CA-positive metastatic breast cancers.

Read More
 | 8 Min. Read |

Next-generation sequencing (NGS) tests

11/18/24 | BY: Pallav K. Mehta

Next-generation sequencing (NGS) is a testing technology that uses computers to look at hundreds of genes in cancer cells. The results can help guide treatment decisions.

Read More
 | 7 Min. Read |

Immunohistochemistry (IHC) tests

11/15/24 | BY: Regina Hampton

Some of the most important breast cancer treatment decisions are based on immunohistochemistry (IHC) tests; hormone receptor status, HER2 status, and in some cases, PD-L1 status.

Read More
 | 7 Min. Read
stay_connected

Stay connected

Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.

about_this_page_tabbed_module
About this page
Glossary
About LBBC

Reviewed and updated: August 31, 2015

Reviewed by: Jennifer Winn, MD, MS

Tagged:

Was this page helpful?

Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.